Functionalized linear poly(amidoamine)s are efficient vectors for intracellular protein delivery

被引:37
作者
Coue, Gregory [1 ]
Engbersen, Johan F. J. [1 ]
机构
[1] Univ Twente, Dept Biomed Chem, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands
关键词
Bioreducible polymers; Disulfide reduction; Intracellular protein delivery; Poly(amidoamine); Polyelectrolyte complex; IN-VITRO; BETA-GALACTOSIDASE; PHYSICOCHEMICAL PROPERTIES; TRANSFECTION EFFICIENCY; ENDOSOMOLYTIC POLYMERS; AMPHOTERIC AGMATINE; GENE DELIVERY; AMINO-GROUPS; NANOPARTICLES; CELLS;
D O I
10.1016/j.jconrel.2011.01.023
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
An effective intracellular protein delivery system was developed based on functionalized linear poly (amidoamine)s (PAAs) that form self-assembled cationic nanocomplexes with oppositely charged proteins. Three differently functionalized PAAs were synthesized, two of these having repetitive disulfide bonds in the main chain, by Michael-type polyaddition of 4-amino-1-butanol (ABOL) to cystamine bisacrylamide (CBA), histamine (HIS) to CBA, and ABOL to bis(acryloyl)piperazine (BAP). These water-soluble PAAs efficiently condense beta-galactosidase by self-assembly into nanoscaled and positively-charged complexes. Stable under neutral extracellular conditions, the disulfide-containing nanocomplexes rapidly destabilized in a reductive intracellular environment. Cell-internalization and cytotoxicity experiments showed that the PAA-based nanocomplexes were essentially non-toxic. beta-Galactosidase was successfully internalized into cells, with up to 94% of the cells showing beta-galactosidase activity, whereas the enzyme alone was not taken up by the cells. The results indicate that these poly(amidoamine)s have excellent properties as highly potent and non-toxic intracellular protein carriers, which should create opportunities for novel applications in protein delivery. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 98
页数:9
相关论文
共 57 条
[1]
Thiomers:: A new generation of mucoadhesive polymers [J].
Bernkop-Schnürch, A .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (11) :1569-1582
[2]
Current strategies for the development of peptide-based anti-cancer therapeutics [J].
Borghouts, C ;
Kunz, C ;
Groner, B .
JOURNAL OF PEPTIDE SCIENCE, 2005, 11 (11) :713-726
[3]
A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[4]
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[5]
2-4
[6]
Amphoteric Agmatine Containing Polyamidoamines as Carriers for Plasmid DNA In Vitro and In Vivo Delivery [J].
Cavalli, Roberta ;
Bisazza, Agnese ;
Sessa, Roberto ;
Primo, Luca ;
Fenili, Fabio ;
Manfredi, Amedea ;
Ranucci, Elisabetta ;
Ferruti, Paolo .
BIOMACROMOLECULES, 2010, 11 (10) :2667-2674
[7]
Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery [J].
Chavanpatil, Mahesh D. ;
Khdair, Ayman ;
Panyam, Jayanth .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) :2651-2663
[8]
CHAWLA RK, 1984, GASTROENTEROLOGY, V87, P770
[9]
Effect of size and serum proteins on transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles [J].
Cherng, JY ;
vandeWetering, P ;
Talsma, H ;
Crommelin, DJA ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1038-1042
[10]
CRAVEN GR, 1964, FED PROC, V23, P263